Literature DB >> 22450690

Monomeric and dimeric models of ERK2 in conjunction with studies on cellular localization, nuclear translocation, and in vitro analysis.

Sunbae Lee1, Yun Soo Bae.   

Abstract

Extracellular signal-regulated protein kinase 2 (ERK2) plays many vital roles in cellular signal regulation. Phosphorylation of ERK2 leads to propagation and execution of various extracellular stimuli, which influence cellular responses to stress. The final response of the ERK2 signaling pathway is determined by localization and duration of active ERK2 at specific target cell compartments through protein-protein interactions of ERK2 with various cytoplasmic and nuclear substrates, scaffold proteins, and anchoring counterparts. In this respect, dimerization of phosphorylated ERK2 has been suggested to be a part of crucial regulating mechanism in various protein-protein interactions. After the report of putative dimeric structure of active ERK2 (Canagarajah et al., 1997), dimeric model was employed to explain many in vivo and in vitro experimental results. But more recently, many reports have been presented questioning the validity of dimer hypothesis of active ERK2. In this review, we summarize the various in vitro and in vivo studies concerning the Monomeric or the dimeric forms of ERK2 and the validity of the dimer hypothesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22450690      PMCID: PMC3887802          DOI: 10.1007/s10059-012-0023-4

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  107 in total

1.  Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro.

Authors:  D J Robbins; E Zhen; H Owaki; C A Vanderbilt; D Ebert; T D Geppert; M H Cobb
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

2.  Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation.

Authors:  G Pagès; P Lenormand; G L'Allemain; J C Chambard; S Meloche; J Pouysségur
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

3.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

4.  Extracellular signal-regulated kinases 2 autophosphorylates on a subset of peptides phosphorylated in intact cells in response to insulin and nerve growth factor: analysis by peptide mapping.

Authors:  D J Robbins; M H Cobb
Journal:  Mol Biol Cell       Date:  1992-03       Impact factor: 4.138

5.  The stress-activated protein kinase subfamily of c-Jun kinases.

Authors:  J M Kyriakis; P Banerjee; E Nikolakaki; T Dai; E A Rubie; M F Ahmad; J Avruch; J R Woodgett
Journal:  Nature       Date:  1994-05-12       Impact factor: 49.962

6.  Energy transfer analysis of Fos-Jun dimerization and DNA binding.

Authors:  L R Patel; T Curran; T K Kerppola
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

7.  A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.

Authors:  J Han; J D Lee; L Bibbs; R J Ulevitch
Journal:  Science       Date:  1994-08-05       Impact factor: 47.728

Review 8.  Dimeric transcription factor families: it takes two to tango but who decides on partners and the venue?

Authors:  K A Lee
Journal:  J Cell Sci       Date:  1992-09       Impact factor: 5.285

9.  The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins.

Authors:  C Wasylyk; A Gutman; R Nicholson; B Wasylyk
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

10.  Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts.

Authors:  P Lenormand; C Sardet; G Pagès; G L'Allemain; A Brunet; J Pouysségur
Journal:  J Cell Biol       Date:  1993-09       Impact factor: 10.539

View more
  4 in total

1.  U0126, an Inhibitor of MEK1/2, Increases Tumor Necrosis Factor-α-Induced Apoptosis, but not Interleukin-6 Induced Apoptosis in C-28/I2 Human Chondrocytes.

Authors:  Charles J Malemud; Aaron C Lewis; Meredith A Wylie; Evan C Meszaros; Yelenna Skomorovska-Prokvolit; Sam Mesiano
Journal:  J Autoimmune Disord       Date:  2015-11-07

Review 2.  Targeting ERK beyond the boundaries of the kinase active site in melanoma.

Authors:  Rachel M Sammons; Ranajeet Ghose; Kenneth Y Tsai; Kevin N Dalby
Journal:  Mol Carcinog       Date:  2019-06-12       Impact factor: 4.784

3.  Genetic visualization of protein interactions harnessing liquid phase transitions.

Authors:  Taku Watanabe; Tatsuya Seki; Takashi Fukano; Asako Sakaue-Sawano; Satoshi Karasawa; Misaki Kubota; Hiroshi Kurokawa; Ken Inoue; Junichi Akatsuka; Atsushi Miyawaki
Journal:  Sci Rep       Date:  2017-04-13       Impact factor: 4.379

Review 4.  ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?

Authors:  Roser Buscà; Jacques Pouysségur; Philippe Lenormand
Journal:  Front Cell Dev Biol       Date:  2016-06-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.